Coronavirus Disease 2019 in Children

Area of Science:

• Pediatrics
• Infectious Diseases
• Virology

Background:

• The global spread of SARS-CoV-2 (COVID-19) revealed a lower incidence and generally milder disease course in children compared to adults.
• Pediatric COVID-19 presents with variable symptoms, often resembling other viral respiratory infections, with a higher prevalence of upper airway involvement.
• While most children exhibit mild to moderate symptoms or remain asymptomatic, severe cases and deaths are rare, primarily occurring in those with pre-existing conditions.

Purpose of the Study:

• To review and synthesize current knowledge on pediatric SARS-CoV-2 infection.
• To provide updated information for healthcare professionals to enhance patient care.
• To explore potential factors contributing to children's relative resistance to severe COVID-19.

Main Methods:

• This is a narrative review, synthesizing existing literature and data on pediatric COVID-19.
• The review analyzes clinical presentations, epidemiological data, and proposed pathogenetic mechanisms.
• It also considers diagnostic advancements and current treatment approaches, including ongoing clinical trials.

Main Results:

• Over 90% of pediatric COVID-19 cases are mild or moderate; asymptomatic infections are common.
• Severe disease and fatalities in children are infrequent and associated with comorbidities.
• Potential protective factors in children include reduced ACE2 receptor expression, enhanced interferon responses, and trained immunity, though mechanisms require further elucidation.

Conclusions:

• Pediatric COVID-19 is predominantly a mild illness, contrasting with the adult experience.
• Understanding the unique immunological and molecular factors in children is crucial for explaining their milder disease.
• Continued research and improved diagnostic strategies are vital for managing pediatric SARS-CoV-2 infections effectively.